Showing results (201-210 of 2,002) with videos related to
Sort By:
Pageof 201
The Journal of the Acoustical Society of America|August 1, 1993
Vowel boundaries for steady-state and linear formant trajectoriesA K Nábĕlek, Z Czyzewski, H J CrowleyJournal of Bacteriology|January 28, 1999
Recovery of DNA replication in UV-irradiated Escherichia coli requires both excision repair and recF protein functionJ Courcelle, D J Crowley, P C HanawaltDrug and Alcohol Dependence|September 1, 1996
Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug usersR E Booth, T J Crowley, Y ZhangAnnals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|March 6, 2009
The revised TNM staging system for lung cancerRamon Rami-Porta, John J Crowley, Peter GoldstrawJournal of the National Cancer Institute|February 1, 1978
Effects of endocrinologic conditions associated with acute versus chronic lactation on the incidence of mammary carcinomas in irradiated rats: brief communicationM N Gould, K H Clifton, J CrowleyAppetite|April 23, 2014
Night eating in patients with type 2 diabetes. Associations with glycemic control, eating patterns, sleep, and moodMegan M Hood, Sirimon Reutrakul, Stephanie J CrowleyInvestigational New Drugs|April 1, 1988
Evaluation of fludarabine phosphate in small cell carcinoma. A Southwest Oncology Group StudyJ M Rainey, J B Hill, J CrowleyDevelopmental Psychobiology|September 29, 2011
Human puberty: salivary melatonin profiles in constant conditionsStephanie J Crowley, Christine Acebo, Mary A CarskadonThe Journal of Laboratory and Clinical Medicine|March 1, 1982
Prognostic value of serum lactic dehydrogenase level in Hodgkin's diseaseR F Schilling, B McKnight, J J CrowleyControlled Clinical Trials|July 29, 2000
Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpointR Mick, J J Crowley, R J CarrollPageof 201